New Cholesterol Pill Offers Alternative to Statins for Patients

A new cholesterol-lowering pill, Nexletol, has been shown to reduce the risk of heart attacks in individuals who are unable to take statins due to side effects or other reasons. The medication, which was approved by the FDA earlier this year, works by blocking an enzyme in the liver that produces LDL or “bad” cholesterol.

According to a recent study, patients who took Nexletol saw a 17% reduction in their risk of heart attack, stroke, and other major cardiovascular events compared to those who took a placebo. The drug is also said to have fewer side effects than statins, such as muscle pain and weakness.

Dr. Robert Harrington, a cardiologist and president of the American Heart Association, called the results “exciting” and said that the drug could be a “game-changer” for patients who can’t tolerate statins.

While Nexletol may be a good alternative for some, experts caution that lifestyle changes such as diet and exercise should still be the first line of defense against high cholesterol. Patients should also consult with their healthcare provider to determine the best treatment plan for their individual needs.

Nexletol is currently available by prescription only and is not recommended for individuals with liver problems or those who are pregnant or breastfeeding.